Patients Admitted to Tertiary Health Care Center: Cancer Screening Program Awareness Study
Main Article Content
Abstract
Background: Screening programs for detecting cancer early are critically important for a better prognosis and a long acting survival. In our country, second most common cause of death is cancers with the rate of 21.1 %. The aim of this study was to investigate cancer screening and awareness in healthy individuals in our region.
Study Design: The survey was conducted on 400 randomly selected patients who were admitted to Pamukkale University hospital with the method of face to face interview in May 2016 Statistical evaluation was performed using SPSS v22.
Results: Of the 400 participants, 192 (45%) were male, and 208 (52%) were female. We found out that stated that they had heard the cancer screening programs 65% and KETEM- Cancer Early Diagnosis and Training Centers name units in Turkey = Kanser Erken Tanı, Tarama ve Eğitim Merkezi - (18,5%).
Only 31.7% of the participants knew the the cancer screening and the proportion who answered correctly was higher among less than 30 years old (p=0.007)
Early diagnosis and treatment of cancer is most of the time lifesaving. In our study we saw that most of the people had less and missing knowledge about cancer early diagnosis. People who had a history of cancer in their family had much more knowledge about cancer screening tests.
Of the 81.5% participants had not heard about KETEM, and 35% had not heard about the cancer screening programs.
Conclusion: Awareness studies for relatives of patients with cancer should be conducted. Due to low rates of correct answers were given to the questions of methods for screening methods, our people should be informed about cancer screening.
Downloads
Article Details
Copyright (c) 2017 Dogu GG, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
https://globocan.iarc.fr/Pages/fact_sheets_population.aspx
Adami HO, Day NE, Trichopoulos D, Willett WC (2001) Primary and secondary prevention in the reduction of cancer morbidity and mortality. Eur J Cancer 37: 118-127. Link: https://goo.gl/CDgBXy
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, et al. (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385: 977-1010. Link: https://goo.gl/TchmeY
Stewart BW, Wild CP (2014) World Cancer Report 2014. Lyon France IARC. Link: https://goo.gl/Bj4WhH
Harford JB (2011) Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 12: 306-312. Link: https://goo.gl/2FlpvB
Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ (2009) Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer 101: 92-101. Link: https://goo.gl/LVQKpz
Richards MA (2009) The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 101: S1-4. Link: https://goo.gl/HDJOiV
Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, et al. (2009) Public awareness of cancer in Britain: a population-based survey of adults. Br J Cancer 101: 18-23. Link: https://goo.gl/Mc0AfD
Fontana SA, Baumann LC, Helberg C, Love RR (1997) The delivery of preventive services in primary care practices according to chronic disease status. Am J Public Health 87: 1190–1196. Link: https://goo.gl/a1SmAJ